Business Description
XTL Biopharmaceuticals Ltd
NAICS : 325412
SIC : 2834
ISIN : IL0010854979
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.6 | |||||
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year FCF Growth Rate | 5.9 | |||||
3-Year Book Growth Rate | -16.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.7 | |||||
9-Day RSI | 27.37 | |||||
14-Day RSI | 33.91 | |||||
6-1 Month Momentum % | -10.81 | |||||
12-1 Month Momentum % | 182.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.43 | |||||
Quick Ratio | 11.43 | |||||
Cash Ratio | 10.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -14.29 | |||||
ROA % | -13.29 | |||||
ROIC % | -181.32 | |||||
3-Year ROIIC % | -8612.5 | |||||
ROCE % | 23.82 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.58 | |||||
Price-to-Tangible-Book | 4.35 | |||||
EV-to-EBIT | 16.3 | |||||
EV-to-EBITDA | 16.3 | |||||
EV-to-FCF | -14.5 | |||||
Price-to-Net-Current-Asset-Value | 4.35 | |||||
Price-to-Net-Cash | 8.7 | |||||
Earnings Yield (Greenblatt) % | 6.13 | |||||
FCF Yield % | -5.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
XTL Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | |||
EPS (TTM) (₪) | -0.001 | ||
Beta | 0 | ||
Volatility % | 207.96 | ||
14-Day RSI | 33.91 | ||
14-Day ATR (₪) | 0.00456 | ||
20-Day SMA (₪) | 0.0929 | ||
12-1 Month Momentum % | 182.86 | ||
52-Week Range (₪) | 0.031 - 0.171 | ||
Shares Outstanding (Mil) | 544.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
XTL Biopharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
XTL Biopharmaceuticals Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
XTL Biopharmaceuticals Ltd Frequently Asked Questions
What is XTL Biopharmaceuticals Ltd(XTAE:XTLB)'s stock price today?
When is next earnings date of XTL Biopharmaceuticals Ltd(XTAE:XTLB)?
Does XTL Biopharmaceuticals Ltd(XTAE:XTLB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |